BACKGROUND AND AIM OF THE STUDY: The degenerative calcification of bioprosthetic heart valves remains a clinical challenge, especially among young adults and children. Animal models that are based on subcutaneous and intramuscular implantation and are typically used to assess interventions to prevent bioprosthetic heart valve calcification do not reflect actual hemodynamic stress and lack direct blood contact. Thus, the study aim was to investigate bioprosthesis calcification at different implantation sites. METHODS: The calcification degrees of five valve implantation methods, namely subcutaneous, intramuscular and intravenous implantation, and arterial and venous patch angioplasty, were simultaneously investigated in 10 New Zealand White...
BACKGROUND AND AIM OF THE STUDY: Glutaraldehyde may promote calcification in xenograft tissue by t...
Pericarbon is a last-generation bovine pericardial valve bioprosthesis, which was designed [I], exp...
Calcification is the principal cause of the clinical failure of bioprosthetic heart valves fabricate...
To study the process of calcification in bioprostheses, valve leaflets were implanted subcutaneously...
Every year a lot of people suffering from congenital or acquired heart valve diseases overcome heart...
Tissue calcification is a major cause of failure of bioprosthetic heart valves. Aim of this study wa...
Tissue calcification is a major cause of failure of bioprosthetic heart valves. Aim of this study wa...
Calcification is the most frequent cause of clinical dysfunction of glutaraldehyde treated bioprosth...
Background: The rat subcutaneous model reproduces clinically observed mineralization of bioprosthet...
Calcification is a recurrent problem in patients suffering from heart valve disease and it is the ma...
Dept. of Medicine/박사There are some evidences that angiotensin II type I receptor blocker (ARB) could...
Aim of the study: A major limitation of currently available bioprosthetic valves is their propensity...
OBJECTIVES: There is evidence that angiotensin II type I receptor blocker (ARB) could reduce structu...
BACKGROUND AND AIMS OF THE STUDY: Pericarbon is a new-generation bovine pericardial bioprosthesis de...
The biomineralization of bovine pericardium (BP) heart valve bioprostheses was investigated by simul...
BACKGROUND AND AIM OF THE STUDY: Glutaraldehyde may promote calcification in xenograft tissue by t...
Pericarbon is a last-generation bovine pericardial valve bioprosthesis, which was designed [I], exp...
Calcification is the principal cause of the clinical failure of bioprosthetic heart valves fabricate...
To study the process of calcification in bioprostheses, valve leaflets were implanted subcutaneously...
Every year a lot of people suffering from congenital or acquired heart valve diseases overcome heart...
Tissue calcification is a major cause of failure of bioprosthetic heart valves. Aim of this study wa...
Tissue calcification is a major cause of failure of bioprosthetic heart valves. Aim of this study wa...
Calcification is the most frequent cause of clinical dysfunction of glutaraldehyde treated bioprosth...
Background: The rat subcutaneous model reproduces clinically observed mineralization of bioprosthet...
Calcification is a recurrent problem in patients suffering from heart valve disease and it is the ma...
Dept. of Medicine/박사There are some evidences that angiotensin II type I receptor blocker (ARB) could...
Aim of the study: A major limitation of currently available bioprosthetic valves is their propensity...
OBJECTIVES: There is evidence that angiotensin II type I receptor blocker (ARB) could reduce structu...
BACKGROUND AND AIMS OF THE STUDY: Pericarbon is a new-generation bovine pericardial bioprosthesis de...
The biomineralization of bovine pericardium (BP) heart valve bioprostheses was investigated by simul...
BACKGROUND AND AIM OF THE STUDY: Glutaraldehyde may promote calcification in xenograft tissue by t...
Pericarbon is a last-generation bovine pericardial valve bioprosthesis, which was designed [I], exp...
Calcification is the principal cause of the clinical failure of bioprosthetic heart valves fabricate...